Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals. | mSphere | 2021 | 34431693 | PubTator, text mining | PubMed |
| Comparing antiviral strategies against COVID-19 via multiscale within-host modelling. | R Soc Open Sci | 2021 | 34430042 | PubTator, text mining | PubMed |
| Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management. | Int Immunopharmacol | 2021 | 34426104 | PubTator, text mining | PubMed |
| Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia. | Elife | 2021 | 34424199 | PubTator, text mining | PubMed |
| Efficacy and sustainability of natural products in COVID-19 treatment development: opportunities and challenges in using agro-industrial waste from Citrus and apple. | Heliyon | 2021 | 34423146 | PubTator, text mining | PubMed |
| Granzyme A Produced by γ9δ2 T Cells Activates ER Stress Responses and ATP Production, and Protects Against Intracellular Mycobacterial Replication Independent of Enzymatic Activity. | Front Immunol | 2021 | 34413857 | PubTator, text mining | PubMed |
| Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells. | J Transl Med | 2021 | 34412632 | PubTator, text mining | PubMed |
| Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. | Cell | 2021 | 34407392 | PubTator, text mining | PubMed |
| Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage. | J Virol | 2021 | 34406867 | PubTator, text mining | PubMed |
| COVID-19 diagnosis by RT-qPCR in alternative specimens. | Mem Inst Oswaldo Cruz | 2021 | 34406222 | PubTator, text mining | PubMed |
| Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. | JCI Insight | 2021 | 34403374 | PubTator, text mining | PubMed |
| The role of NK cells in fighting the virus infection and sepsis. | Int J Med Sci | 2021 | 34400893 | PubTator, text mining | PubMed |
| The "oral" history of COVID-19: Primary infection, salivary transmission, and post-acute implications. | J Periodontol | 2021 | 34390597 | PubTator, text mining | PubMed |
| Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. | Sci Immunol | 2021 | 34376481 | PubTator, text mining | PubMed |
| Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. | Cell Discov | 2021 | 34373443 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma. | Front Oncol | 2021 | 34367994 | PubTator, text mining | PubMed |
| Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome. | Front Immunol | 2021 | 34367157 | PubTator, text mining | PubMed |
| Single-Cell RNA-Seq of T Cells in B-ALL Patients Reveals an Exhausted Subset with Remarkable Heterogeneity. | Adv Sci (Weinh) | 2021 | 34365737 | PubTator, text mining | PubMed |
| Acute Kidney Injury in COVID-19. | Int J Mol Sci | 2021 | 34360866 | PubTator, text mining | PubMed |
| Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 34359727 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=84